Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,572 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Weekly chemotherapy as Induction chemotherapy in locally advanced head and neck cancer for patients ineligible for 3 weekly maximum tolerable dose chemotherapy.
Patil VM, Noronha V, Joshi A, Muddu VK, Dhumal S, Arya S, Juvekar S, Pai P, Chatturvedi P, Devendra AC, Ghosh S, D'cruz A, Kumar P. Patil VM, et al. Among authors: arya s. Indian J Cancer. 2014 Jan-Mar;51(1):20-4. doi: 10.4103/0019-509X.134608. Indian J Cancer. 2014. PMID: 24947091 Free article.
A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck.
Patil VM, Noronha V, Joshi A, Muddu VK, Dhumal S, Bhosale B, Arya S, Juvekar S, Banavali S, D'Cruz A, Bhattacharjee A, Prabhash K. Patil VM, et al. Among authors: arya s. Oral Oncol. 2015 Mar;51(3):279-86. doi: 10.1016/j.oraloncology.2014.12.002. Epub 2015 Jan 8. Oral Oncol. 2015. PMID: 25578869 Clinical Trial.
Neoadjuvant chemotherapy in geriatric head and neck cancers.
Patil VM, Noronha V, Joshi A, Ramaswamy A, Dhumal S, Juvekar S, Arya S, Mahajan A, Chaturvedi P, D'Cruz A, Bhattacharjee A, Prabhash K. Patil VM, et al. Among authors: arya s. Head Neck. 2017 May;39(5):886-892. doi: 10.1002/hed.24694. Epub 2017 Mar 1. Head Neck. 2017. PMID: 28248432
Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer.
Joshi A, Patil V, Noronha V, Dhumal S, Pande N, Chandrasekharan A, Turkar S, DSouza H, Shrirangwar S, Mahajan A, Arya S, Juvekar S, BhattaCharjee A, Prabhash K. Joshi A, et al. Among authors: arya s. Oral Oncol. 2017 Dec;75:54-60. doi: 10.1016/j.oraloncology.2017.10.018. Epub 2017 Nov 5. Oral Oncol. 2017. PMID: 29224823 Clinical Trial.
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Patil VM, Noronha V, Joshi A, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, Mahimkar M, Juvekar S, Arya S, Mahajan A, Agarwal A, Purandare N, Rangarajan V, Balaji A, Chaudhari SV, Banavali S, Kannan S, Bhattacharjee A, D'Cruz AK, Chaturvedi P, Pai PS, Chaukar D, Pantvaidya G, Nair D, Nair S, Deshmukh A, Thiagarajan S, Mathrudev V, Manjrekar A, Dhumal S, Maske K, Bhelekar AS, Nawale K, Chandrasekharan A, Pande N, Goel A, Talreja V, Simha V, Srinivas S, Swami R, Vallathol DH, Dsouza H, Shrirangwar S, Turkar S, Abraham G, Thanky AH, Patel U, Pandey MK, Prabhash K. Patil VM, et al. Among authors: arya s. Cancer. 2019 Sep 15;125(18):3184-3197. doi: 10.1002/cncr.32179. Epub 2019 May 31. Cancer. 2019. PMID: 31150120 Free article. Clinical Trial.
Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity Cancer.
Chaukar D, Prabash K, Rane P, Patil VM, Thiagarajan S, Ghosh-Laskar S, Sharma S, Pai PS, Chaturvedi P, Pantvaidya G, Deshmukh A, Nair D, Nair S, Vaish R, Noronha V, Patil A, Arya S, D'Cruz A. Chaukar D, et al. Among authors: arya s. J Clin Oncol. 2022 Jan 20;40(3):272-281. doi: 10.1200/JCO.21.00179. Epub 2021 Dec 6. J Clin Oncol. 2022. PMID: 34871101 Clinical Trial.
Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?
Patil V, Noronha V, Joshi A, Muddu Krishna V, Juvekar S, Pantvaidya G, Chaturvedi P, Chaukar D, Arya S, Patil A, Bhosale B, Dongre A, Dcruz AK, Prabhash K. Patil V, et al. Among authors: arya s. ISRN Oncol. 2013 Sep 11;2013:259154. doi: 10.1155/2013/259154. eCollection 2013. ISRN Oncol. 2013. PMID: 24109521 Free PMC article.
1,572 results